Formation EUBC : How Robotization Can Help mRNA Production ?

Inscription

Les inscriptions sont fermées

Formation EUBC : How Robotization Can Help mRNA Production ?

Introduction

During the global COVID-19 crisis, an extraordinary challenge was met: designing, in just one year, a robotic machine capable of producing mRNA at scale. This bold endeavor, undertaken by Quantoom, Equans, and Staubli, pushed the boundaries of bioproduction innovation to address the urgent need for vaccines and therapies.

Step into this remarkable story, where cutting-edge technology and unparalleled expertise came together to achieve the impossible. Discover how strategic decisions, such as the integration of robotic arms, full process automation, and interdisciplinary collaboration, turned a groundbreaking vision into an operational reality.

This program takes you to the heart of this industrial and scientific revolution. You will master the tools and technologies shaping the future of biopharmaceutical production. More than just a training, it’s an immersion into innovation at the service of humanity’s greatest challenges. Join us to enhance your skills and become a key player in the bioproduction of tomorrow.

Key informations 

Date : 27-28th March 2025 

Format : Presential, 2 days 

Where : BioPark Charleroi, BT4, Belgium 

Price : TBC  

Partner : Equans, Staubli, Quantoom 

Full program : See below 

Description 

This program offers a deep dive into the innovative processes behind the development of a fully automated robotic system for mRNA production. Designed by industry leaders Quantoom, Equans, and Staubli, this system represents a milestone in biopharmaceutical manufacturing, addressing the growing demand for scalable, high-quality solutions.

Through interactive sessions led by robotics and biomanufacturing experts, you will gain insights into the key technologies and strategic decisions that made this achievement possible. Explore the advantages and challenges of automation, the rationale behind selecting robotic arms, and the lessons learned during the system’s development.

More than a focus on technology, this training emphasizes the principles of integration and continuous processing, enabling efficient and cost-effective production of therapies. By the end of the program, you will have the knowledge and tools to drive innovation and tackle critical challenges in biopharma manufacturing.

Seize the opportunity to elevate your expertise and be part of shaping the future of the industry.

Learning Objectives

By the end of this program, participants will:

  1. Understand the technologies behind robotics and their potential applications within the biotech and biopharma industries.
  2. Identify the limitations and challenges of various robotic technologies and assess their suitability for specific manufacturing needs.
  3. Recognize the critical role of technology integration in addressing biopharma manufacturing challenges and improving efficiency and scalability.
  4. Analyze real-world case studies to draw actionable insights from successful implementations by leading industry experts.
  5. Develop practical skills to apply robotics and automation solutions to real-world biomanufacturing problems.
  6. Gain strategic knowledge to drive innovation in biopharmaceutical production and meet growing market demands.

 

Unique & Original 

Don’t let this opportunity slip away. 

Dive into this fascinating story to uncover its full logic and development, all narrated by the experts themselves, with direct application on the machines—a truly unique opportunity.

🔒 [SÉCURISEZ VOTRE PLACE MAINTENANT]

Inscription

Les inscriptions sont fermées
Date et heure
jeudi 27 mars 2025
Commence à 08:00 (Europe/Brussels)
vendredi 28 mars 2025
Fin - 15:00 (Europe/Brussels)

Ajouter au calendrier

Emplacement

Brussels South Charleroi BioPark

Rue Clément Ader10
6041 Charleroi
Belgique
+32 476 20 73 22
office@biopark.be

Obtenez l'itinéraire

Organisateur

EU Biotech Campus

--EU Biotech Campus--
PARTAGER

Découvrez ce que les gens voient et disent à propos de cet événement et rejoignez la conversation.